| NCT |
Route |
Dose |
Times |
Masking |
EDSS |
Selection criteria |
Out-comes |
| 01377870 |
IV |
? |
Single |
DB |
3-6.5 |
D |
AE, EDSS, MSFC, RAO, B-C. MRI, QOL |
| 01895439 |
IV |
? |
Single |
OL |
<=6 |
ND |
AE, B.MRI, OPHTHALMIC TESTS |
| 01883661 |
IV |
? |
6 in one month |
OL |
? |
ND |
AE, EDSS, QOL, B.MRI, CSF, VEP |
| 01844957 |
IV |
1-2x10(6)/kg |
Single |
DB |
3-6.5 |
D |
B.MRI, Relapse, EDSS |
| 01364246 |
IV |
? |
? |
OL |
? |
ND |
AE, EDSS, BAER, SSEP, VEP, B.MRI |
| 01730547 |
IV |
? |
? |
DB |
3-6.5 |
D |
AE, B.MRI, Relapse, Disability progression |
| 01056471 |
IV |
10(6), 4x10(6)/kg |
Single |
DB |
>=5.5, <=9 |
D |
AE, B.MRI, IMMUNOLOGY, NEUROPHYSIOLOGY, NEUROPSYCHOLOGY |
| 01228266 |
IV |
2x10(6)/kg |
Single |
DB |
3-6.5 |
D |
AE, Clinical, B.MRI, OCT, IMMUNOLOGY, GOL |
| 00813969 |
IV |
2x10(6)/kg |
Single |
OL |
3-6.5 |
D |
AE, B.MRI, Disease activity |
| 01745783 |
IV |
2x10(6)/kg |
Single |
DB |
? |
D |
AE, B.MRI, EDSS, MSFC, QOL, Disease free patients |
| 01933802 |
IV |
2-10x10(6)/kg |
3 each three months |
OL |
>=3 |
D |
AE, Evoked potentials, QOL, EDSS, MSFC, B.MRI |
| 01606215 |
IV |
2x10(6)/kg |
Single |
DB |
3-6.5 |
D |
AE, B.MRI, MSFC, EDSS, IMMUNOLOGY |
| ----------- |
IV |
1-2x10(6)/kg |
Single |
DB |
3-6.5 |
D |
? |
| 01453764 |
IV, IT |
? |
Single |
OL |
? |
ND |
AE, EDSS, Relapse |
| 01932593 |
IV |
? |
Single |
OL |
? |
ND |
AE, Evoked potentials, B.MRI, EDSS, MSFC, MSIS-29 |
| 00927108 |
? |
? |
? |
OL |
? |
ND |
? |
| 01815632 |
IV |
1.5X10x8/kg |
Twice |
DB |
4.0-6.0 |
D |
Global EP, Safety, EDSS, MSIS, MSFC, B-C. MRI, OCT |
|
